Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this clinical trial is to evaluate the safety and efficacy of rhEGF
(recombinant human Epidermal Growth Factor) in diabetic foot ulcer patients with uncontrolled
diabetes mellitus.